Literature DB >> 20187769

Effect of non-nucleoside reverse transcriptase inhibitors on cytokine, chemokine, and immunoglobulin profiles in serum and genital secretions of HIV-infected women.

Ravinder Kaur Sachdeva1, Ajay Wanchu, Rashmi Bagga, Nancy Malla, Meera Sharma.   

Abstract

Non-protease inhibitor-based antiretroviral therapy (ART) is widely accepted as first-line ART in developing countries. Although reverse transcriptase inhibitor-based regimens have been studied in the peripheral blood, no studies have analyzed alterations in cytokine and chemokine levels, together in peripheral blood and genital secretions. Forty HIV-infected women with CD4 cell counts <200 cells/mm(3), asymptomatic, with no genital tract infection, willing to participate in the study, and adhere to ART were enrolled. Cervicovaginal lavage (CVL) was collected in the mid-cycle phase of menstrual cycle. Patients were initiated with reverse transcriptase-based antiretrovirals. Repeat sampling was performed at 24 weeks. Cytokines and chemokines were measured using ultrasensitive ELISA kits. Viral load declined to undetectable levels in 29 patients in the blood and in 33 cases in the CVL. Proinflammatory cytokines (tumor necrosis factor-alpha [TNF-alpha, interleukin-6 [IL-6], IL-1beta) in the serum and CVL showed a significant decrease in mean levels after therapy. IL-2 levels increased significantly whereas IL-12 and (IFN-gamma decreased in both compartments. Mean levels of IL-4 and IL-10 decreased significantly in the serum. There was direct correlation between serum and CVL levels of IL-2 and IL-10. IL-10 had a negative correlation with CD4% at baseline and 6 months of therapy. Mean levels of all alpha- and beta-chemokines decreased in serum after therapy. In CVL, mean levels of MIP-1alpha, RANTES, and IL-8 reduced and SDF-1alpha increased significantly (P value <0.001). Serum levels of all the cytokines, except IL-2, and all chemokines prior to therapy, were significantly higher than healthy controls. In CVL, mean levels of TNF-alpha, IL-6, IL-1beta, IL-12, IFN-gamma, IL-10, RANTES, and IL-8 were significantly higher, whereas IL-2, MIP-1alpha, and MIP-1beta were significantly lower than healthy controls. The mean levels of proinflammatory cytokines and chemokines significantly decreased in serum and CVL after therapy, possibly due to reduced viral load.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187769     DOI: 10.1089/jir.2009.0056

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  9 in total

1.  Effect of HIV and chlamydia infection on rectal inflammation and cytokine concentrations in men who have sex with men.

Authors:  Marlies Heiligenberg; René Lutter; Dasja Pajkrt; Karin Adams; Henry De Vries; Titia Heijman; Maarten F Schim van der Loeff; Suzanne Geerlings
Journal:  Clin Vaccine Immunol       Date:  2013-07-31

2.  Effects of tenofovir on cytokines and nucleotidases in HIV-1 target cells and the mucosal tissue environment in the female reproductive tract.

Authors:  Nabanita Biswas; Marta Rodriguez-Garcia; Zheng Shen; Sarah G Crist; Jack E Bodwell; John V Fahey; Charles R Wira
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

3.  Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.

Authors:  Judith A Aberg; Pablo Tebas; Edgar Turner Overton; Samir K Gupta; Paul E Sax; Alan Landay; Ron Falcon; Robert Ryan; Guy De La Rosa
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-02       Impact factor: 2.205

4.  Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection.

Authors:  Christophe Vanpouille; Andrea Introini; Sheldon R Morris; Leonid Margolis; Eric S Daar; Michael P Dube; Susan J Little; David M Smith; Andrea Lisco; Sara Gianella
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

5.  Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy.

Authors:  Cynthia Gay; Oliver Dibben; Jeffrey A Anderson; Andrea Stacey; Ashley J Mayo; Philip J Norris; JoAnn D Kuruc; Jesus F Salazar-Gonzalez; Hui Li; Brandon F Keele; Charles Hicks; David Margolis; Guido Ferrari; Barton Haynes; Ronald Swanstrom; George M Shaw; Beatrice H Hahn; Joseph J Eron; Persephone Borrow; Myron S Cohen
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

6.  Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.

Authors:  Pascale Ondoa; Raju Gautam; John Rusine; Rene Lutter; Suzanne Jurriaans; Neeltje Kootstra; Etienne Karita; Janneke van de Wijgert
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

7.  The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects.

Authors:  Faustina Nkechi Osuji; Charles Chinedu Onyenekwe; Joseph Ebere Ahaneku; Nkiruka Rose Ukibe
Journal:  J Biomed Sci       Date:  2018-12-03       Impact factor: 8.410

8.  Semen IgM, IgG1, and IgG3 Differentially Associate With Pro-Inflammatory Cytokines in HIV-Infected Men.

Authors:  Thevani Pillay; Parveen Sobia; Abraham Jacobus Olivier; Kapil Narain; Lenine J P Liebenberg; Sinaye Ngcapu; Mesuli Mhlongo; Jo-Ann S Passmore; Cheryl Baxter; Derseree Archary
Journal:  Front Immunol       Date:  2019-01-23       Impact factor: 7.561

9.  Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy.

Authors:  Frederikke F Rönsholt; Henrik Ullum; Terese L Katzenstein; Jan Gerstoft; Sisse R Ostrowski
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.